In-vitro transcription buffer solution, transcription reaction system and application

By using magnesium chloride and poly(2-dimethylamino)methacrylate in the in vitro transcription buffer, combined with RNase inhibitors and inorganic pyrophosphatases, the instability of RNases in mRNA generation was solved, achieving high mRNA yield and integrity.

CN118910038APending Publication Date: 2024-11-08艾美荣誉(宁波)生物制药有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411031753.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-30
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

In existing technologies, RNases in the environment affect the stability and yield of mRNA production during long-term experiments.

Method used

An in vitro transcription buffer containing magnesium chloride and poly(2-dimethylamino)methacrylate was used, which, combined with RNase inhibitors and inorganic pyrophosphatase, formed a stable complex to protect DNA and RNA and improve their stability. The transcription efficiency was optimized by adjusting the concentration of RNA polymerase and the ratio of the components.

Benefits of technology

It effectively improves the stability and yield of mRNA, reduces the risk of RNase degradation, and ensures the continuous progress of transcription and the quality of the product.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004970103920000061
    Figure BDA0004970103920000061
  • Figure BDA0004970103920000091
    Figure BDA0004970103920000091
  • Figure BDA0004970103920000101
    Figure BDA0004970103920000101
Patent Text Reader

Abstract

The invention relates to the technical field of DNA transcription, in particular to an in-vitro transcription buffer solution, a transcription reaction system and application. The in-vitro transcription buffer solution is prepared from the following components in concentration: 200mM of tris (hydroxymethyl) aminomethane hydrochloride, 125mM of sodium chloride, 10mM of spermidine, 80 to 120mM of magnesium chloride and 20 to 40mM of poly (2-dimethylamino) ethyl methacrylate. Through the synergistic effect of poly (2-dimethylamino) ethyl methacrylate and magnesium chloride, poly (2-dimethylamino) ethyl methacrylate can effectively improve the stability and solubility of DNA and RNA in a transcription system, and magnesium chloride can improve the binding efficiency of RNA polymerase. The influence on the transcription efficiency after the poly (2-dimethylamino) ethyl methacrylate is combined with the DNA is reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of DNA transcription, and in particular to an in vitro transcription buffer, a transcription reaction system and applications. Background Art

[0002] As a substance that carries genetic information and can directly determine protein translation, mRNA has attracted the attention of scientists since it was first discovered in 1961. In the 1990s, scientists conducted a series of preclinical studies on mRNA in vitro transcription to further explore its application in disease treatment.

[0003] In vitro synthesis of mRNA is mainly obtained by in vitro reverse transcription using cDNA as a template. The most common method is to use plasmid DNA as a template and use RNA polymerase to transcribe and synthesize. At present, in vitro synthesis of mRNA is mainly obtained by using RNA in vitro transcription kits containing RNA polymerase. It uses linearized plasmid DNA as a template and uses NTP as a substrate to synthesize mRNA complementary to one strand of the template DNA from the downstream of the promoter under the condition of containing RNA polymerase (T7, T3 or SP6), so as to obtain a large number of mRNA molecules simply and quickly.

[0004] Due to the constant presence of RNases in the environment, during long experiments, a small amount of RNases will always be mixed into the entire transcription system, thus affecting the final mRNA produced. Summary of the invention

[0005] In order to solve the problem of RNA enzymes in the environment affecting the final generated mRNA, the present application provides an in vitro transcription buffer, a transcription reaction system and an application. The magnesium chloride and poly (2-dimethylamino) ethyl methacrylate present in the in vitro transcription buffer can effectively maintain the stability of the generated mRNA while increasing the yield of the mRNA.

[0006] In a first aspect, the present application provides an in vitro transcription buffer, which adopts the following technical solution: An in vitro transcription buffer comprising the following components at the following concentrations: Tris(hydroxymethyl)aminomethane hydrochloride 200 mM, sodium chloride 125 mM, spermidine 10 mM, magnesium chloride 80-120 mM, poly(2-dimethylamino)ethyl methacrylate 20-40 mM.

[0007] By adopting the above technical solution, poly(2-dimethylamino)ethyl methacrylate, as a polymer, has a certain buffering capacity. During in vitro transcription, the stability of pH value is crucial for enzyme activity and transcription efficiency. Poly(2-dimethylamino)ethyl methacrylate can absorb or release protons, thereby maintaining the pH stability in the entire buffer, ensuring that RNA polymerase and other enzymes work under optimal pH conditions.

[0008] Poly(2-dimethylamino)ethyl methacrylate) carries a positive charge and can bind to negatively charged DNA and RNA to form a stable complex. This combination not only protects DNA and RNA from enzyme cleavage or other degradation processes, but also improves their stability and solubility in the transcription system.

[0009] Magnesium chloride is one of the key coenzyme factors of RNA polymerase. During in vitro transcription, magnesium chloride can stabilize the active center of RNA polymerase, promote its correct recognition of DNA templates and initiate the transcription process. At the same time, magnesium chloride can also bind to the transcription product RNA to protect it from enzyme cutting and other degradation.

[0010] In the case of poly(2-dimethylamino)ethyl methacrylate binding to DNA, the addition of magnesium chloride can further promote the binding of RNA polymerase. Since the complex formed by poly(2-dimethylamino)ethyl methacrylate and DNA may hinder the binding of RNA polymerase to a certain extent, magnesium chloride can enhance the affinity between DNA and RNA polymerase in the complex by interacting with them, thereby improving the binding efficiency of RNA polymerase and thus improving the transcription efficiency of DNA.

[0011] The present application uses the synergistic effect of poly(2-dimethylamino)ethyl methacrylate and magnesium chloride. Poly(2-dimethylamino)ethyl methacrylate can effectively improve the stability and solubility of DNA and RNA in the transcription system, and magnesium chloride can improve the binding efficiency of RNA polymerase and reduce the influence of poly(2-dimethylamino)ethyl methacrylate on the transcription efficiency after binding to DNA.

[0012] Preferably, the concentration ratio of poly(2-dimethylamino)ethyl methacrylate to magnesium chloride is 1:3-4.

[0013] By adopting the above technical solution, magnesium chloride is a coenzyme factor of RNA polymerase, which is essential for the activity and stability of RNA polymerase. An appropriate amount of magnesium chloride can stabilize the active center of RNA polymerase, promote its correct binding with the DNA template and the initiation of the transcription process. When the magnesium chloride concentration is too high, it may exceed the optimal concentration range of RNA polymerase, resulting in inhibition of RNA polymerase activity. Excessive magnesium chloride concentration may change the binding mode of the enzyme with the substrate, interfere with the correct folding and function of the enzyme, and thus reduce transcription efficiency.

[0014] Poly(2-dimethylamino)ethyl methacrylate also has a certain selectivity in binding to DNA and RNA, forming a stable complex and protecting it from degradation. However, when the concentration of magnesium chloride is too high, it may destroy the interaction between poly(2-dimethylamino)ethyl methacrylate and DNA / RNA, affecting the stability of the entire system.

[0015] In a second aspect, the present application provides a transcription reaction system, which adopts the following technical solution: A transcription reaction system comprises the above-mentioned in vitro transcription buffer.

[0016] By adopting the above technical solution, the advantages of the transcription reaction system compared with the prior art are the same as those of the in vitro transcription buffer, which will not be repeated here.

[0017] Preferably, the transcription reaction system further comprises components of the following concentrations: cap analog 6.75 mM, ATP 6.75 mM, N1-Me-pUTP 6.75 mM, CTP 6.75 mM, GTP 6.75 mM, plasmid 0.05 mg / mL, T7 RNA polymerase 15-30 U / μL.

[0018] By adopting the above technical scheme, the addition of cap analogs (such as m7G(5')ppp(5')G) can simulate the 5' cap structure of eukaryotic mRNA, which is very important for improving the efficiency of transcription initiation and the stability of mRNA. After the cap analogs bind to the 5' end of the mRNA precursor, they can prevent RNA degradation and facilitate the nuclear export and translation initiation of mRNA. The concentrations of ATP, N1-Me-pUTP, CTP and GTP are the same, which provides a balanced environment, helps to ensure that the consumption rate of each nucleotide is similar during transcription, and reduces the possibility of transcription termination.

[0019] T7 RNA polymerase is an efficient and specific RNA polymerase that can synthesize mRNA from plasmid DNA at a very high rate in vitro. By adjusting the concentration of T7 RNA polymerase (15-30U / μL), you can ensure the transcription efficiency while avoiding non-specific reactions or waste of enzyme activity caused by excessive enzyme concentration.

[0020] Preferably, the volume fraction of the in vitro transcription buffer in the transcription reaction system is 8-12%.

[0021] By adopting the above technical scheme, the volume fraction of the in vitro transcription buffer affects the final concentration of poly(2-dimethylamino)ethyl methacrylate and magnesium chloride in the entire transcription reaction system. If the concentration of PDMAEMA (poly(2-dimethylamino)ethyl methacrylate) is too high, it may bind to DNA too tightly, which may cause certain regions of the DNA template to be over-shielded, thereby hindering the correct binding of RNA polymerase to DNA and the initiation of transcription. This excessive DNA-PDMAEMA binding may lead to low transcription efficiency or even transcription failure.

[0022] If MgCl 2 If the concentration is too high, it may non-specifically bind to other components in the system, resulting in an excessively high ionic strength of the entire system, thereby affecting the activity and stability of RNA polymerase. 2 The concentration may also interfere with the correct folding of RNA and the stability of the transcript.

[0023] When PDMAEMA and MgCl 2 When the concentration is too low, the reaction buffer has limited effect in promoting the entire transcription reaction system.

[0024] Preferably, the transcription reaction system further comprises 2 U / μL of RNase inhibitor.

[0025] By adopting the above technical solution, the main function of the RNase inhibitor is to inhibit the activity of RNase, thereby protecting RNA from degradation by RNase during transcription, extraction, purification and storage. During in vitro transcription, due to the influence of experimental conditions and environment, RNase may contaminate the transcription system at any time, resulting in degradation of the transcription product. Therefore, adding RNase inhibitor can effectively prevent the degradation of the transcribed RNA.

[0026] There are many types of RNase inhibitors, including diethyl pyrocarbonate (DEPC), guanidine isothiocyanate, vanadyl ribonucleoside complexes, and protein inhibitors of RNase (such as RNasin). These inhibitors inhibit RNase activity through different mechanisms of action with RNase. For example, diethyl pyrocarbonate denatures proteins by binding to the active groups of RNase, while guanidine isothiocyanate inactivates RNase by destroying cell structures. These inhibitors have their own characteristics, but they can all play an effective role in protecting RNA in the transcription reaction system.

[0027] Preferably, the concentration of the T7 RNA polymerase is 15-25 U / μL.

[0028] By adopting the above technical solution, RNase inhibitors can inhibit RNA degradation, thereby improving the stability and accumulation of transcription products. Then the transcribed RNA can be retained in the reaction system for a longer time, reducing the need for transcription termination and repeated initiation due to RNA degradation. In addition, the maximum concentration of RNA polymerase is reduced from 30U / μL before adding RNase inhibitors to 25U / μL. It can reduce the increase of non-specific binding and background noise caused by excessive RNA polymerase concentration, thereby affecting the quality and purity of the transcription product.

[0029] If the concentration of RNA polymerase is too low, the rate and efficiency of the transcription reaction may be reduced, resulting in insufficient amount of transcription product to meet the experimental requirements. Too low RNA polymerase concentration may lead to incomplete transcription reaction, that is, some regions on the DNA template are not completely transcribed into RNA, which will affect the integrity and function of the transcription product.

[0030] Preferably, the transcription reaction system further comprises 7.5 U / mL of inorganic pyrophosphatase.

[0031] By adopting the above technical scheme, the role of inorganic pyrophosphatase is to catalyze the hydrolysis of inorganic pyrophosphate (PPi) during transcription. PPi is released during the process of RNA polymerase catalyzing the polymerization of NTPs (nucleotide triphosphates) into RNA chains. The accumulation of PPi inhibits the binding of NTPs to RNA polymerase, thereby reducing the transcription efficiency. The presence of inorganic pyrophosphatase can convert PPi into inorganic phosphate (Phosphate, Pi), thereby maintaining the effective binding between NTPs and RNA polymerase, thereby maintaining the continuous transcription reaction.

[0032] Preferably, the concentration of the T7 RNA polymerase is 15-20 U / μL.

[0033] By adopting the above technical scheme, inorganic pyrophosphatase hydrolyzes PPi, reducing the inhibitory effect of PPi on the transcription reaction, thereby maintaining the transcription efficiency. In this case, the RNase inhibitor has been added. Even if the concentration of RNA polymerase decreases, the amount of transcription product can still meet the experimental needs because the transcription efficiency is maintained. In addition, the maximum concentration of RNA polymerase is reduced from 25U / μL before the addition of inorganic pyrophosphatase to 20U / μL. The non-specific binding and increase of background noise caused by excessive RNA polymerase concentration can be reduced, thereby affecting the quality and purity of the transcription product.

[0034] If the concentration of RNA polymerase is too low, the rate and efficiency of the transcription reaction may be reduced, resulting in insufficient amount of transcription product to meet the experimental requirements. Too low RNA polymerase concentration may lead to incomplete transcription reaction, that is, some regions on the DNA template are not completely transcribed into RNA, which will affect the integrity and function of the transcription product.

[0035] In a third aspect, the present application provides an mRNA in vitro transcription kit, which adopts the following technical solution: An mRNA in vitro transcription kit comprises the above-mentioned transcription reaction system.

[0036] By adopting the above technical solution, the advantages of the mRNA in vitro transcription kit over the prior art are the same as those of the above transcription reaction system, which will not be repeated here.

[0037] In summary, this application has the following beneficial effects: 1. Due to the synergistic effect of poly(2-dimethylamino)ethyl methacrylate and magnesium chloride, poly(2-dimethylamino)ethyl methacrylate can effectively improve the stability and solubility of DNA and RNA in the transcription system, and magnesium chloride can improve the binding efficiency of RNA polymerase and reduce the effect of poly(2-dimethylamino)ethyl methacrylate on transcription efficiency after binding to DNA; 2. The present application adds RNase inhibitors and inorganic pyrophosphatase to the transcription system, which can effectively reduce the decomposition of mRNA and maintain the effective binding between NTPs and RNA polymerase, thereby maintaining the continuous progress of the transcription reaction. DETAILED DESCRIPTION

[0038] The raw materials in this application include the following parts: Tris(hydroxymethyl)aminomethane hydrochloride: a commercially available product with CAS number 1185-53-1; Sodium chloride: a commercially available product with CAS number 7647-14-5; Spermidine: a commercially available product with CAS number 124-20-9 was used; Magnesium chloride: a commercially available product with CAS number 7786-30-3; Poly(2-dimethylamino)ethyl methacrylate): a commercially available product with CAS No. 2867-47-2; Cap analogs: There are many types of cap analogs, including m7Gdiammonium, 3'Ome-m7GpppAmpGammonium, Cap1-GAG, and Cap1-GAG containing 3'OMe modification. This application uses a commercially available product of Cap1-GAG as an example, and its structure is m7G(5')ppp(5')(2'OMeA)pG; ATP: commercially available products were used; N1-Me-pUTP: commercially available product; CTP: Use commercially available products; GTP: Use commercially available products; Plasmid: commercially available products are used. This application uses S2P-IND2-XbaⅠ plasmid as an example; T7 RNA polymerase: commercially available product; RNase inhibitors: There are many types of RNase inhibitors, including diethyl pyrocarbonate (DEPC), guanidine isothiocyanate, vanadyl ribonucleoside complexes, and protein inhibitors of RNase (such as RNasin), etc. This application uses a commercially available product of diethyl pyrocarbonate with a CAS number of 1609-47-8 as an example; Inorganic pyrophosphatase: a commercially available product with CAS number 9024-82-2; Water: a commercial product with CAS number 7732-18-5 was used; The present application is further described in detail below in conjunction with embodiments and comparative examples.

[0039] Example 1 A method for preparing an in vitro transcription buffer comprises the following steps: 31.5 g of tris(hydroxymethyl)aminomethane hydrochloride, 7.3 g of sodium chloride, 1.5 g of spermidine, 9.5 g of magnesium chloride, and 4.72 g of poly(2-dimethylamino)ethyl methacrylate were added to sterile water and mixed. The final volume of the mixture was adjusted to 1 L to obtain an in vitro transcription buffer, wherein the concentrations of the components in the in vitro transcription buffer were: 200 mM tris(hydroxymethyl)aminomethane hydrochloride, 125 mM sodium chloride, 10 mM spermidine, 100 mM magnesium chloride, and 30 mM poly(2-dimethylamino)ethyl methacrylate.

[0040] A transcription method for a transcription reaction system comprises the following steps: Preparation: Take 40.5 mL of 100 mM Cap1-GAG, 40.5 mL of 100 mM ATP, 40.5 mL of 100 mM N1-Me-pUTP, 40.5 mL of 100 mM CTP, 40.5 mL of 100 mM GTP, 30 mL of 1 mg / mL S2P-IND2-XbaⅠ plasmid, 60 mL of 260 U / μL T7 RNA polymerase, and 60 mL of in vitro transcription reaction solution, add sterile water to supplement the transcription reaction system to 600 mL, and vortex to mix together to obtain the transcription reaction system. The concentrations of the components in the transcription reaction system are: cap analog 6.75 mM, ATP 6.75 mM, N1-Me-pUTP 6.75 mM, CTP 6.75 mM, GTP 6.75 mM, plasmid 0.05 mg / mL, T7 RNA polymerase 26U / μL, the volume fraction of in vitro transcription reaction solution is 10%; transcription: react the above transcription reaction system at 37°C for 2.5h, then add DNase I, mix well and incubate at 37°C for 30min to remove the residual DNA template and obtain crude mRNA; Purification: The crude mRNA is purified by RNA Cleaner magnetic beads to remove proteins, free nucleotides, etc. to obtain mRNA.

[0041] Example 2-3 Example 2-3 Based on the preparation method of Example 1, the concentrations of poly (2-dimethylamino) ethyl methacrylate (PDMAEMA) and magnesium chloride in the in vitro transcription buffer were adjusted. The specific adjustments are shown in Table 1.

[0042] Comparative Examples 1-3 Comparative Example 1-3 Based on the preparation method of Example 1, the concentrations of poly (2-dimethylamino) ethyl methacrylate and magnesium chloride in the in vitro transcription buffer were adjusted. The specific adjustments are shown in Table 1.

[0043] Table 1 Concentration table of poly (2-dimethylamino) ethyl methacrylate and magnesium chloride in the in vitro transcription buffer of Examples 1-3 and Comparative Examples 1-3 and performance test table Performance Test The mRNA of Examples 1-3 and Comparative Examples 1-3 were subjected to the following performance tests. The test results are shown in Table 1: 1. mRNA yield The concentration of mRNA was detected by ultra-micro UV spectrophotometer, and the yield of mRNA was determined by measuring the A260 reading of the product, and the mRNA yield was obtained as follows: (mRNA yield / plasmid addition amount)*100%.

[0044] 2. mRNA integrity The Bioptic Qsep100 Bio-Fragment Analyzer is used to evaluate the integrity and quality of mRNA. It only requires a small amount of mRNA for analysis. High-quality mRNA should show a single and sharp peak on the graph, and the size of the peak position should be consistent with expectations.

[0045] Referring to Table 1, by comparing Examples 1-3 and Comparative Examples 1-3, it can be seen that compared with Comparative Example 3, the mRNA yield and mRNA integrity of Examples 1-3 are much higher than those of Comparative Example 3, indicating that the addition of poly (2-dimethylamino) ethyl methacrylate and magnesium chloride to mRNA can effectively improve the binding efficiency of RNA polymerase and improve the stability of mRNA, thereby effectively improving the yield and integrity of mRNA; Similarly, the mRNA yield and mRNA integrity of Examples 1-3 are higher than those of Comparative Examples 1-2; for Comparative Example 1, magnesium chloride is not added to the mRNA, and although the binding of poly(2-dimethylamino)ethyl methacrylate to mRNA can improve stability, poly(2-dimethylamino)ethyl methacrylate also binds to the template DNA, changing the structure of the template DNA, thereby reducing the binding efficiency of RNA polymerase and thus reducing the mRNA yield; for Comparative Example 2, poly(2-dimethylamino)ethyl methacrylate is not added to the mRNA, and although magnesium chloride improves the binding efficiency of RNA polymerase, the lack of poly(2-dimethylamino)ethyl methacrylate to bind to template DNA and RNA reduces the integrity of mRNA; therefore, poly(2-dimethylamino)ethyl methacrylate and magnesium chloride need to be added to the mRNA at the same time to effectively improve the mRNA yield and integrity; in comparison, the mRNA yield and integrity of Example 1 are preferred among Examples 1-3.

[0046] Embodiment 4-7 Example 4-7 Based on the preparation method of Example 1, the concentration of magnesium chloride is adjusted, and the specific adjustment is shown in Table 2.

[0047] The mRNA of Examples 4-7 was subjected to the above performance tests, and the test results are shown in Table 2.

[0048] Table 2 Concentration and performance test table of magnesium chloride of embodiment 1 and embodiment 4-7 project Example 1 Example 4 Example 5 Example 6 Example 7 Magnesium chloride / mM 30 25 33.3 20 40 Yield / % 163.2 141.5 152.7 119.3 136.4 Completeness / % 85.3 80.8 83.3 75.9 80.0 Referring to Table 2, by comparing Example 1 with Examples 4-7, it can be seen that as the concentration of magnesium chloride increases, the mRNA yield and mRNA integrity both show a trend of first increasing and then decreasing. This may be because as the concentration of magnesium chloride increases, magnesium chloride continuously improves the binding efficiency of T7 RNA polymerase, thereby increasing the mRNA yield and integrity; when the concentration of magnesium chloride exceeds a certain range, it may change the binding mode of the enzyme and the substrate, interfere with the correct folding and function of the enzyme, reduce the transcription efficiency, and thus reduce the mRNA yield and integrity.

[0049] Embodiment 8-9 In Example 8-9, based on the preparation method of Example 1, the concentration of T7 RNA polymerase was adjusted. The specific adjustment is shown in Table 3.

[0050] Comparative Examples 4-5 Comparative Example 4-5 Based on the preparation method of Example 1, the concentration of T7 RNA polymerase was adjusted. The specific adjustments are shown in Table 3.

[0051] The mRNA of Examples 8-9 and Comparative Examples 4-5 were subjected to the above performance tests, and the test results are shown in Table 3.

[0052] Table 3 T7 RNA polymerase and performance test table of Example 1, Examples 8-9 and Comparative Examples 4-5 project Example 1 Example 8 Example 9 Comparative Example 4 Comparative Example 5 T7 RNA polymerase / (U / μL) 26 15 30 12 32 Yield / % 163.2 103.8 145.4 86.8 121.7 Completeness / % 85.3 72.9 81.8 69.0 77.1 Referring to Table 3, it can be seen from Example 1, Examples 8-9 and Comparative Examples 4-5 that as the concentration of T7 RNA polymerase increases, both the mRNA yield and the mRNA integrity show a trend of first increasing and then decreasing. This may be because as the concentration of T7 RNA polymerase increases, T7 RNA polymerase can synthesize mRNA from plasmid DNA at a very high rate in vitro, continuously improving the binding efficiency of T7 RNA polymerase, thereby increasing the mRNA yield and integrity; when the concentration of T7 RNA polymerase exceeds a certain range, the nonspecific reaction or waste of enzyme activity caused by the excessively high enzyme concentration reduces the mRNA yield and integrity.

[0053] Embodiment 10-11 In Example 10-11, based on the preparation method of Example 1, the volume fraction of the in vitro transcription buffer was adjusted, and the specific adjustment is shown in Table 4.

[0054] In Comparative Example 6-7, based on the preparation method of Example 1, the volume fraction of the in vitro transcription buffer was adjusted, and the specific adjustment is shown in Table 4.

[0055] The mRNA of Examples 10-11 and Comparative Examples 6-7 were subjected to the above performance tests, and the test results are shown in Table 4.

[0056] Table 4 Volume fraction and performance test table of in vitro transcription buffer of Example 1, Examples 10-11 and Comparative Examples 6-7 project Example 1 Example 10 Embodiment 11 Comparative Example 6 Comparative Example 7 In vitro transcription buffer / % 10 8 12 6 14 Yield / % 163.2 132.8 140.6 90.2 128.4 Completeness / % 85.3 78.9 80.9 69.7 78.4 Referring to Table 4, it can be seen from Example 1, Example 10-11 and Comparative Example 6-7 that as the volume fraction of the in vitro transcription buffer increases, the mRNA yield and mRNA integrity both show a trend of increasing and then decreasing. This may be due to the fact that as the volume fraction of the in vitro transcription buffer increases, poly(2-dimethylamino)ethyl methacrylate continues to bind to DNA and RNA respectively, and magnesium chloride continues to improve the binding efficiency of T7 RNA polymerase, thereby continuously improving the mRNA yield and integrity; when exceeding a certain range, the concentration of poly(2-dimethylamino)ethyl methacrylate is too high, and it may bind too tightly to DNA, which may cause certain areas of the DNA template to be over-shielded, thereby hindering the correct binding of RNA polymerase to DNA and the initiation of transcription. The concentration of magnesium chloride is too high, and it may non-specifically bind to other components in the system, resulting in excessive ionic strength of the entire system, affecting the activity and stability of RNA polymerase, thereby reducing the mRNA yield and integrity.

[0057] Examples 12-14 Example 12 Based on the preparation method of Example 1, 30 mL of 40 U / μL diethyl pyrocarbonate is further added to the transcription reaction system, so that the concentration of diethyl pyrocarbonate in the transcription reaction system is 2 U / μL, and the concentration of T7 RNA polymerase in the transcription reaction system is adjusted to 22 U / μL, and other conditions remain unchanged.

[0058] Example 13-14 Based on the preparation method of Example 12, the concentration of T7 RNA polymerase was adjusted. The specific adjustment is shown in Table 5.

[0059] Comparative Examples 8-9 Comparative Example 8-9 Based on the preparation method of Example 12, the concentration of T7 RNA polymerase was adjusted, and the specific adjustment is shown in Table 5.

[0060] The mRNA of Examples 12-14 and Comparative Examples 8-9 were subjected to the above performance tests, and the test results are shown in Table 5 respectively.

[0061] Table 5 Concentration and performance test table of T7 RNA polymerase in Example 1, Examples 12-14 and Comparative Examples 8-9 Referring to Table 5, by comparing Example 1, Examples 12-14 and Comparative Examples 8-9, it can be seen that when diethyl pyrocarbonate is added, diethyl pyrocarbonate denatures the RNase by binding to the active group of the RNase, thereby effectively protecting the RNA, thereby improving the stability and accumulation of the transcription product; the transcribed RNA can be retained in the reaction system for a longer time, reducing the need for transcription termination and repeated initiation due to RNA degradation.

[0062] As the concentration of T7 RNA polymerase continued to increase, the mRNA yield and mRNA integrity both showed a trend of first increasing and then decreasing. This may be because as the concentration of T7 RNA polymerase continued to increase, T7 RNA polymerase was able to synthesize mRNA from plasmid DNA at an extremely high rate in vitro, continuously improving the binding efficiency of T7 RNA polymerase, thereby increasing the mRNA yield and integrity; when the concentration of T7 RNA polymerase exceeded a certain range, the nonspecific reaction or waste of enzyme activity caused by the excessively high enzyme concentration reduced the mRNA yield and integrity.

[0063] Examples 15-17 Example 15 Based on the preparation method of Example 12, 45 mL of 0.1 U / μL inorganic pyrophosphatase is further added to the transcription reaction system, so that the concentration of inorganic pyrophosphatase in the transcription reaction system is 7.5 U / mL. In addition, the concentration of T7 RNA polymerase in the transcription reaction system is adjusted to 22 U / μL, and other conditions remain unchanged.

[0064] In Examples 16-17, based on the preparation method of Example 15, the concentration of T7 RNA polymerase was adjusted, and the specific adjustments are shown in Table 6.

[0065] Comparative Examples 10-11 Comparative Examples 10-11 Based on the preparation method of Example 15, the concentration of T7 RNA polymerase was adjusted, and the specific adjustments are shown in Table 6.

[0066] The mRNA of Examples 15-17 and Comparative Examples 10-11 were subjected to the above performance tests, and the test results are shown in Table 6.

[0067] Table 6 Concentration and performance test table of T7 RNA polymerase in Example 12, Examples 15-17 and Comparative Examples 10-11 Referring to Table 6, by comparing Example 12, Examples 15-17 and Comparative Examples 10-11, it can be seen that when inorganic pyrophosphatase is added, the presence of inorganic pyrophosphatase can convert PPi into inorganic phosphate, thereby maintaining the effective binding between NTPs and RNA polymerase, thereby maintaining the continuous transcription reaction.

[0068] As the concentration of T7 RNA polymerase continued to increase, the mRNA yield and mRNA integrity both showed a trend of first increasing and then decreasing. This may be because as the concentration of T7 RNA polymerase continued to increase, T7 RNA polymerase was able to synthesize mRNA from plasmid DNA at an extremely high rate in vitro, continuously improving the binding efficiency of T7 RNA polymerase, thereby increasing the mRNA yield and integrity; when the concentration of T7 RNA polymerase exceeded a certain range, the nonspecific reaction or waste of enzyme activity caused by the excessively high enzyme concentration reduced the mRNA yield and integrity.

[0069] Application Examples According to the transcription reaction systems of Examples 1-17, corresponding kits can be prepared, and the kits can be effectively used in relevant in vitro transcription experiments.

[0070] This specific embodiment is merely an explanation of the present application and is not a limitation of the present application. After reading this specification, those skilled in the art may make modifications to the present embodiment without any creative contribution as needed, but such modifications are protected by the patent law as long as they are within the scope of the claims of the present application.

Claims

1. An in vitro transcription buffer, It is characterized in that Includes components in the following concentrations: Tris(hydroxymethyl)aminomethane hydrochloride 200mM, sodium chloride 125mM, spermidine 10mM, magnesium chloride 80-120mM, poly(2-dimethylamino)ethyl methacrylate 20-40mM.

2. The in vitro transcription buffer according to claim 1, Features: The concentration ratio of the poly(2-dimethylamino)ethyl methacrylate to magnesium chloride is 1:3-4.

3. A transcription reaction system, Features: Comprising the in vitro transcription buffer as described in claim 1 or 2.

4. The transcription reaction system according to claim 3, Features: Also included were components at the following concentrations: cap analog 6.75 mM, ATP 6.75 mM, N1-Me-pUTP 6.75 mM, CTP 6.75 mM, GTP 6.75 mM, plasmid 0.05 mg / mL, T7 RNA polymerase 15-30 U / μL.

5. The transcription reaction system according to claim 4, Features: The volume fraction of the in vitro transcription buffer in the transcription reaction system is 8-12%.

6. The transcription reaction system according to claim 4, Features: 2 U / μL of RNase inhibitor was also included.

7. The transcription reaction system according to claim 6, Features: The concentration of the T7 RNA polymerase is 15-25 U / μL.

8. The transcription reaction system according to claim 6, Features: Also included was 7.5 U / mL of inorganic pyrophosphatase.

9. The transcription reaction system according to claim 8, Features: The concentration of the T7 RNA polymerase is 15-20 U / μL.

10. An mRNA in vitro transcription kit, Features: The method comprises the transcription reaction system as described in any one of claims 3 to 9.